Giorgio Marengo

Giorgio Marengo

Auto-generated profile, based on publicly available information

Giorgio Marengo

University of Turin and Città della Salute della Scienza, Turin

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2023 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
OFOvidio De Filippo
Ovidio De Filippo
AFAntonino Di Franco
Antonino Di Franco
PBPaolo Boretto
Paolo Boretto
FBFrancesco Bruno
Francesco Bruno
VCVincenzo Cusenza
Vincenzo Cusenza
MGMario Gaudino
Mario Gaudino

1 August 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
FBFrancesco Bruno
Francesco Bruno
GMGiorgio Marengo
Giorgio Marengo
OFOvidio De Filippo
Ovidio De Filippo
WWWojciech Wańha
Wojciech Wańha
SLSergio Leonardi
Sergio Leonardi
COCollaborators
Collaborators
Background: The impact of complete revascularization (CR) on the development of heart failure (HF) in patients with acute coronary syndrome and multivessel coronary artery disease undergoing percutaneous coronary intervention remains to be elucidated. Methods and Results: Consecutive patients with acute coronary syndrome with multivessel coronary artery disease from the CORALYS (Incidence and Predictors of Heart Failure After Acute Coronary Syndrome) registry were included. Incidence of first hospitalization for HF or cardiovascular death was the primary end point. Patients were stratified according to completeness of coronary revascularization. Of 14 699 patients in the CORALYS registry, 5054 presented with multivessel disease. One thousand four hundred seventy‐three (29.2%) underwent CR, while 3581 (70.8%) did not. Over 5 years follow‐up, CR was associated with a reduced incidence of the primary end point (adjusted hazard ratio [HR], 0.66 [95% CI, 0.51–0.85]), first HF hospitalization (adjusted HR, 0.67 [95% CI, 0.49–0.90]) along with all‐cause death and cardiovascular death alone (adjusted HR, 0.74 [95% CI, 0.56–0.97] and HR, 0.56 [95% CI, 0.38–0.84], respectively). The results were consistent in the propensity‐score matching population and in inverse probability treatment weighting analysis. The benefit of CR was consistent across acute coronary syndrome presentations (HR, 0.59 [95% CI, 0.39–0.89] for ST‐segment elevation myocardial infarction and HR, 0.71 [95% CI, 0.50–0.99] for non‐ST‐elevation acute coronary syndrome) and in patients with left ventricular ejection fraction >40% (HR, 0.52 [95% CI, 0.37–0.72]), while no benefit was observed in patients with left ventricular ejection fraction ≤40% (HR, 0.77 [95% CI, 0.37–1.10], P for interaction 0.04). Conclusions: CR after acute coronary syndrome reduced the risk of first hospitalization for HF and cardiovascular death, as well as first HF hospitalization, and cardiovascular and overall death both in patients with ST‐segment elevation myocardial infarction and non‐ST‐elevation acute coronary syndrome. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT 04895176.

14 December 2020 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
FBFrancesco Bruno
Francesco Bruno
Fabrizio D'AscenzoFabrizio D'Ascenzo
Fabrizio D'Ascenzo
GMGiorgio Marengo
Giorgio Marengo
RMRoberto Manfredi
Roberto Manfredi
ASAndrea Saglietto
Andrea Saglietto
GFGaetano Maria De Ferrari
Gaetano Maria De Ferrari

29 April 2022 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
FBFrancesco Bruno
Francesco Bruno
EEEdoardo Elia
Edoardo Elia
Fabrizio D'AscenzoFabrizio D'Ascenzo
Fabrizio D'Ascenzo
GMGiorgio Marengo
Giorgio Marengo
PDPierre Deharo
Pierre Deharo
FCFederico Conrotto
Federico Conrotto

1 January 2024 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
GMGiorgio Marengo
Giorgio Marengo
CCCarlos Cortés
Carlos Cortés
JSJuan Pablo Sánchez-Luna
Juan Pablo Sánchez-Luna
JGJose Carlos Gonzalez-Gutiérrez
Jose Carlos Gonzalez-Gutiérrez
JHJavier Gómez Herrero
Javier Gómez Herrero
Ignacio J. Amat-SantosIgnacio J. Amat-Santos
Ignacio J. Amat-Santos

Verified
Journal Article
Open access
PDF file
Ignacio J. Amat-SantosIgnacio J. Amat-Santos
Ignacio J. Amat-Santos
GMGiorgio Marengo
Giorgio Marengo
JSJuan Pablo Sánchez-Luna
Juan Pablo Sánchez-Luna
CVCarlos Cortés Villar
Carlos Cortés Villar
FRFERNANDO RIVERO
FERNANDO RIVERO
JCJosé Alberto San Román Calvar
José Alberto San Román Calvar
Background: Quantitative flow ratio (QFR) virtual angioplasty with pre-PCI residual QFR showed better results compared with an angiographic approach to assess post-PCI functional results. However, correlation with pre-PCI residual QFR and post-PCI fractional flow reserve (FFR) is lacking. Methods: A multicenter prospective study including consecutive patients with angiographically 50–90% coronary lesions and positive QFR results. All patients were evaluated with QFR, hyperemic and non-hyperemic pressure ratios (NHPR) before and after the index PCI. Pre-PCI residual QFR (virtual angioplasty) was calculated and compared with post-PCI fractional flow reserve (FFR), QFR and NHPR. Results: A total of 84 patients with 92 treated coronary lesions were included, with a mean age of 65.5 ± 10.9 years and 59% of single vessel lesions being the left anterior descending artery in 69%. The mean vessel diameter was 2.82 ± 0.41 mm. Procedural success was achieved in all cases, with a mean number of implanted stents of 1.17 ± 0.46. The baseline QFR value was 0.69 ± 0.12 and baseline FFR and NHPR were 0.73 ± 0.08 and 0.82 ± 0.11, respectively. Mean post-PCI FFR increased to 0.87 ± 0.05 whereas residual QFR had been estimated as 0.95 ± 0.05, showing poor correlation with post-PCI FFR (0.163; 95% CI:0.078–0.386) and low diagnostic accuracy (30.9%, 95% CI:20–43%). Conclusions: In this analysis, the results of QFR-based virtual angioplasty did not seem to accurately correlate with post-PCI FFR.